Analyzing MPN subjects who had experienced thrombotic complications, we found that these subjects were more likely to be positive for aPLA antibodies in combination with GP Ia/IIa c.807 CT or TT genotype (T allele) than subjects without thrombosis. This evidence concerns the gene ITGA2 and deep vein thrombosis.